Activity of mycobacterial promoters during intracellular and extracellular growth.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 7551043)

Published in Microbiology on August 01, 1995

Authors

O A Dellagostin1, G Esposito, L J Eales, J W Dale, J McFadden

Author Affiliations

1: Molecular Microbiology Group, School of Biological Sciences, University of Surrey, Guildford, UK.

Articles citing this

Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev (2003) 4.14

Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog. J Bacteriol (1996) 4.05

Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.62

Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One (2010) 1.75

Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans. Clin Vaccine Immunol (2006) 1.26

Mycobacterial transcriptional signals: requirements for recognition by RNA polymerase and optimal transcriptional activity. Nucleic Acids Res (2006) 1.21

Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun (2000) 1.18

Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect Immun (2000) 1.17

Identification and analysis of "extended -10" promoters from mycobacteria. J Bacteriol (1998) 1.05

Characterization of the two Mycobacterium tuberculosis recA promoters. J Bacteriol (2003) 0.96

Recombinant Mycobacterium bovis BCG as an HIV vaccine vector. Curr HIV Res (2010) 0.90

Regulation of pyr gene expression in Mycobacterium smegmatis by PyrR-dependent translational repression. J Bacteriol (2007) 0.84

Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds. Antimicrob Agents Chemother (2013) 0.83

Functional characterization of a small heat shock protein from Mycobacterium leprae. BMC Microbiol (2008) 0.81

Small heat-shock protein HspL is induced by VirB protein(s) and promotes VirB/D4-mediated DNA transfer in Agrobacterium tumefaciens. Microbiology (2009) 0.81

Functional insights by comparison of modeled structures of 18kDa small heat shock protein and its mutant in Mycobacterium leprae. Bioinformation (2008) 0.80

The small heat-shock protein HspL is a VirB8 chaperone promoting type IV secretion-mediated DNA transfer. J Biol Chem (2010) 0.78

Drug effects on intracellular mycobacteria determined by mass spectrometric analysis of the Na(+)-to-K+ ratios of individual bacterial organisms. Antimicrob Agents Chemother (1996) 0.76

The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigen. PLoS One (2014) 0.75

The Chromosomal parDE2 Toxin-Antitoxin System of Mycobacterium tuberculosis H37Rv: Genetic and Functional Characterization. Front Microbiol (2016) 0.75

Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin. Mem Inst Oswaldo Cruz (2017) 0.75

Role of Subunit Exchange and Electrostatic Interactions on the Chaperone Activity of Mycobacterium leprae HSP18. PLoS One (2015) 0.75

Interaction of ATP with a small heat shock protein from Mycobacterium leprae: effect on its structure and function. PLoS Negl Trop Dis (2015) 0.75

Articles by these authors

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol (1993) 45.22

Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis. J Clin Microbiol (1990) 15.64

Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect Immun (1991) 14.45

Characterization of a Mycobacterium tuberculosis insertion sequence belonging to the IS3 family. Mol Microbiol (1990) 10.36

Polymorphic repetitive DNA sequences in Mycobacterium tuberculosis detected with a gene probe from a Mycobacterium fortuitum plasmid. J Gen Microbiol (1989) 7.37

Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84

Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J Appl Bacteriol (1992) 4.83

Sequence of the OXA2 beta-lactamase: comparison with other penicillin-reactive enzymes. FEBS Lett (1985) 3.69

Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet (1992) 3.42

R-factor-mediated beta-lactamases that hydrolyze oxacillin: evidence for two distinct groups. J Bacteriol (1974) 2.93

Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ (1993) 2.58

The purification and properties of the -lactamase specified by the resistance factor R-1818 in Escherichia coli and Proteus mirabilis. Biochem J (1971) 2.53

Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax (2002) 2.53

Identification of a UK outbreak strain of Neisseria meningitidis with a DNA probe. Lancet (1990) 2.37

Demonstration of homology between IS6110 of Mycobacterium tuberculosis and DNAs of other Mycobacterium spp.? J Clin Microbiol (1995) 2.21

H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med (2000) 2.20

Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A (1997) 2.19

Characterization of the -lactamase specified by the resistance factor R-1818 in E. coli K12 and other Gram-negative bacteria. Biochem J (1971) 2.10

Histological recovery and gluten-free diet adherence: a prospective 1-year follow-up study of adult patients with coeliac disease. Aliment Pharmacol Ther (2014) 2.09

Versajet hydrosurgery in burn wound debridement: a preliminary experience. Burns (2007) 2.08

Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest (2001) 2.03

Some relationships between R-factor and chromosomal -lactamase in Gram-negative bacteria. Biochem J (1971) 2.03

The dimeric nature of an R-factor mediated beta-lactamase. Biochem Biophys Res Commun (1976) 1.85

Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet (1992) 1.83

Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med (1995) 1.81

PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol (1996) 1.71

Plasmid-determined beta-lactamase indistinguishable from the chromosomal beta-lactamase of Escherichia coli. J Bacteriol (1976) 1.69

Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol (1996) 1.68

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol (2001) 1.67

Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol (2000) 1.66

Insertion sequence typing of Mycobacterium tuberculosis: characterization of a widespread subtype with a single copy of IS6110. Tuber Lung Dis (1994) 1.66

Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth (2007) 1.63

Oxacillin-hydrolysing beta-lactamases. A comparative analysis at nucleotide and amino acid sequence levels. Eur J Biochem (1989) 1.56

Characterization of IS1110, a highly mobile genetic element from Mycobacterium avium. Mol Microbiol (1994) 1.49

High-resolution 1H NMR study of the solution structure of alamethicin. Biochemistry (1987) 1.49

Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol (1994) 1.47

A direct comparison of two unusual R-factor-mediated -lactamases. Biochem J (1972) 1.46

A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology (2000) 1.45

Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol (2002) 1.44

Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem (2000) 1.43

Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet (2005) 1.43

Gene replacement by homologous recombination in Mycobacterium bovis BCG. Mol Microbiol (1995) 1.42

Long-term cyclosporin for psoriasis. Br J Dermatol (1989) 1.42

Fluvoxamine increases plasma and urinary levels of clozapine and its major metabolites in a time- and dose-dependent manner. J Clin Psychopharmacol (2000) 1.41

Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection. Lancet (1987) 1.41

Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol (2006) 1.36

Cloning and expression of Mycobacterium bovis BCG DNA in "Streptomyces lividans". J Bacteriol (1986) 1.35

A molecular code dictates sequence-specific DNA recognition by homeodomains. EMBO J (1996) 1.34

Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from patients with pulmonary tuberculosis in northern Tanzania. Trans R Soc Trop Med Hyg (1995) 1.33

Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis (1999) 1.30

Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism. J Bacteriol (2005) 1.28

Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol (1995) 1.28

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry (2000) 1.28

Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci (2006) 1.28

Plasmid analysis of Mycobacterium avium-intracellulare (MAI) isolated in the United Kingdom from patients with and without AIDS. J Med Microbiol (1991) 1.27

Context-sensitive transposition of IS6110 in mycobacteria. Microbiology (1999) 1.26

Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med (1997) 1.24

Microbicidal activity of monocyte derived macrophages in AIDS and related disorders. Clin Exp Immunol (1987) 1.23

Influence of the transport of amino acids on glucose and sodium transport across the small intestine of the albino rat incubated in vitro. Experientia (1964) 1.19

Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci (1996) 1.18

Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation (2001) 1.18

Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med (2000) 1.15

Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn Reson Med (2004) 1.15

A method for clinical categorization of emergency facilities. Emerg Med Serv (1980) 1.14

The application of molecular techniques to the diagnosis and epidemiology of mycobacterial diseases. Soc Appl Bacteriol Symp Ser (1996) 1.13

Restriction fragment length polymorphism analysis of epidemiologically related Mycobacterium tuberculosis isolates. Microbiol Immunol (1993) 1.12

Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J Am Coll Cardiol (2001) 1.12

Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol (2000) 1.11

Biomolecular electrostatics with the linearized Poisson-Boltzmann equation. Biophys J (1999) 1.10

Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence. Biotechnol Bioeng (2004) 1.10

Uncoupling cognitive workload and prefrontal cortical physiology: a PET rCBF study. Neuroimage (1998) 1.09

Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil (2009) 1.09

Complications of pediatric laparoscopic surgery. Surg Endosc (1997) 1.09

Brain activation during encoding and recognition of verbal and figural information in older adults. Neurobiol Aging (2005) 1.08

Stimulation of transposition of the Mycobacterium tuberculosis insertion sequence IS6110 by exposure to a microaerobic environment. Mol Microbiol (1999) 1.08

The magnetic immuno-polymerase chain reaction assay for the detection of Campylobacter in milk and poultry. Lett Appl Microbiol (1996) 1.07

Improved purification and characterization of the OXA-2 beta-lactamase. Biochem J (1984) 1.06

Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles. Microbiology (2001) 1.06

Cloning and characterization of the gene for the '19 kDa' antigen of Mycobacterium bovis. J Gen Microbiol (1990) 1.05

Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma. Br Med J (Clin Res Ed) (1987) 1.05

Functional mapping of human sensorimotor cortex with 3D BOLD fMRI correlates highly with H2(15)O PET rCBF. J Cereb Blood Flow Metab (1996) 1.05

Transglutaminase 1 deficiency and corneocyte collapse: an indication for targeted molecular screening in autosomal recessive congenital ichthyosis. Br J Dermatol (2007) 1.02

Naturally occurring insertional inactivation of the porA gene of Neisseria meningitidis by integration of IS1301. Mol Microbiol (1998) 1.01

Does Mycobacterium tuberculosis have plasmids? Tubercle (1990) 1.01

S100B is not a reliable prognostic index in paediatric TBI. Pediatr Neurosurg (2007) 1.00

Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene. AIDS Res Hum Retroviruses (1999) 1.00

A new rat model of small vessel stenting. Basic Res Cardiol (2000) 1.00

IS900-promoted stable integration of a foreign gene into mycobacteria. Mol Microbiol (1991) 1.00

Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility. Biochem Biophys Res Commun (1997) 0.99

Lipid synthesis in mycobacteria: characterization of the biotin carboxyl carrier protein genes from Mycobacterium leprae and M. tuberculosis. J Bacteriol (1994) 0.99

Group-specific component and AIDS: erroneous data. Lancet (1988) 0.98

Transpositional activity of IS986 in Mycobacterium smegmatis. Gene (1993) 0.98

Polymerase chain reaction for detection of Mycobacterium leprae in nasal swab specimens. J Clin Microbiol (1993) 0.98

A high resolution 1H NMR study of the solution structure of human epidermal growth factor. FEBS Lett (1986) 0.98

Immunological comparison between OXA-2 beta-lactamase and those mediated by other R plasmids. Antimicrob Agents Chemother (1985) 0.98

The effect of a plasmid on growth and survival of E. coli. Antonie Van Leeuwenhoek (1979) 0.98

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res (1993) 0.97

Abdominothoracic gastric teratoma in a female newborn infant. J Pediatr Surg (1983) 0.97